Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America.

PubWeight™: 5.70‹?› | Rank: Top 1%

🔗 View Article (PMID 16876664)

Published in Lancet on July 29, 2006

Authors

Prabhat Jha1, Richard Peto, Witold Zatonski, Jillian Boreham, Martin J Jarvis, Alan D Lopez

Author Affiliations

1: Centre for Global Health Research, St Michael's Hospital, Public Health Sciences, University of Toronto, Toronto M5C1N8, Canada. prabhat.jha@utoronto.ca

Articles citing this

(truncated to the top 100)

Use of mass media campaigns to change health behaviour. Lancet (2010) 6.33

Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer (2009) 3.14

Socioeconomic Disparities in Health Behaviors. Annu Rev Sociol (2010) 2.99

Will cardiovascular disease prevention widen health inequalities? PLoS Med (2010) 2.89

Population tobacco control interventions and their effects on social inequalities in smoking: systematic review. Tob Control (2008) 2.76

Socioeconomic disparities in quit intentions, quit attempts, and smoking abstinence among smokers in four western countries: findings from the International Tobacco Control Four Country Survey. Nicotine Tob Res (2010) 2.18

Did hardening occur among smokers in England from 2000 to 2010? Addiction (2013) 2.14

Social determinants of health and tobacco use in thirteen low and middle income countries: evidence from Global Adult Tobacco Survey. PLoS One (2012) 1.86

The promise of prevention: the effects of four preventable risk factors on national life expectancy and life expectancy disparities by race and county in the United States. PLoS Med (2010) 1.78

Assessing the impact of smoking cessation services on reducing health inequalities in England: observational study. Tob Control (2007) 1.71

Explaining low mortality among US immigrants relative to native-born Americans: the role of smoking. Int J Epidemiol (2011) 1.68

Cause-specific inequalities in mortality in Scotland: two decades of change. A population-based study. BMC Public Health (2007) 1.64

Subjective social status affects smoking abstinence during acute withdrawal through affective mediators. Addiction (2010) 1.60

The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries. Cancer Causes Control (2012) 1.53

Canada's perceived lack of leadership on global tobacco control. CMAJ (2010) 1.38

Chronic cigarette smoking: implications for neurocognition and brain neurobiology. Int J Environ Res Public Health (2010) 1.36

A Systematic Review of Neighborhood Disparities in Point-of-Sale Tobacco Marketing. Am J Public Health (2015) 1.29

Should doctors advocate snus and other nicotine replacements? Yes. BMJ (2008) 1.22

Trends in the genetic influences on smoking. J Health Soc Behav (2010) 1.22

Socioeconomic inequality in smoking in low-income and middle-income countries: results from the World Health Survey. PLoS One (2012) 1.21

Effect of tobacco smoking on survival of men and women by social position: a 28 year cohort study. BMJ (2009) 1.21

Relation of smoking status to a panel of inflammatory markers: the framingham offspring. Atherosclerosis (2008) 1.20

Population composition, public policy, and the genetics of smoking. Demography (2011) 1.18

Smoking and socioeconomic status in England: the rise of the never smoker and the disadvantaged smoker. J Public Health (Oxf) (2012) 1.17

Education inequality in mortality: The age and gender specific mediating effects of cigarette smoking. Soc Sci Res (2010) 1.17

Association between area-level socioeconomic deprivation and a cluster of behavioural risk factors: cross-sectional, population-based study. J Public Health (Oxf) (2010) 1.16

Association of smoking cessation with financial stress and material well-being: results from a prospective study of a population-based national survey. Am J Public Health (2007) 1.16

Smoking and increased Alzheimer's disease risk: a review of potential mechanisms. Alzheimers Dement (2014) 1.15

Socioeconomic disparities in community-based treatment of tobacco dependence. Am J Public Health (2012) 1.12

The role of tobacco in cancer health disparities. Curr Oncol Rep (2009) 1.11

Educational differences in healthy behavior changes and adherence among middle-aged Americans. J Health Soc Behav (2013) 1.08

Successful smoking cessation and duration of abstinence--an analysis of socioeconomic determinants. Int J Environ Res Public Health (2010) 1.06

Socioeconomic variation in the prevalence, introduction, retention, and removal of smoke-free policies among smokers: findings from the International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health (2011) 1.03

All-cause and cause-specific mortality of different migrant populations in Europe. Eur J Epidemiol (2015) 1.00

Behavioural therapy for smoking cessation: the effectiveness of different intervention types for disadvantaged and affluent smokers. Addict Behav (2013) 1.00

Is the "Glasgow effect" of cigarette smoking explained by socio-economic status?: a multilevel analysis. BMC Public Health (2009) 0.98

The influence of health disparities on targeting cancer prevention efforts. Am J Prev Med (2014) 0.98

Social characteristics associated with disparities in smoking rates in Israel. Isr J Health Policy Res (2016) 0.95

Life course transitions in early adulthood and SES disparities in tobacco use. Soc Sci Res (2013) 0.95

A Competing Neurobehavioral Decision Systems model of SES-related health and behavioral disparities. Prev Med (2014) 0.93

Trends in socioeconomic inequalities in cancer mortality in Barcelona: 1992-2003. BMC Public Health (2009) 0.93

The changing contribution of smoking to educational differences in life expectancy: indirect estimates for Finnish men and women from 1971 to 2010. J Epidemiol Community Health (2012) 0.93

Barriers to effective tobacco-dependence treatment for the very poor. J Stud Alcohol Drugs (2012) 0.92

Mortality among adults: gender and socioeconomic differences in a Brazilian city. BMC Public Health (2012) 0.92

Male tobacco smoke load and non-lung cancer mortality associations in Massachusetts. BMC Cancer (2008) 0.91

Is income or employment a stronger predictor of smoking than education in economically less developed countries? A cross-sectional study in Hungary. BMC Public Health (2011) 0.91

Continued increases in the relative risk of death from smoking. Am J Public Health (2012) 0.88

The effect of smoking on allogeneic transplant outcomes. Biol Blood Marrow Transplant (2009) 0.88

Tobacco smoking, associated risk behaviours, and experience with quitting: a qualitative study with homeless smokers addicted to drugs and alcohol. BMC Public Health (2013) 0.88

"I don't mind damaging my own body" a qualitative study of the factors that motivate smokers to quit. BMC Public Health (2015) 0.87

Time trends in mortality associated with depression: findings from the Stirling County study. Can J Psychiatry (2010) 0.86

Noncommunicable diseases risk factor surveillance: experience and challenge from India. Indian J Community Med (2011) 0.86

Enhancing dissemination of smoking cessation quitlines through T2 translational research: a unique partnership to address disparities in the delivery of effective cessation treatment. J Public Health Manag Pract (2010) 0.84

The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis (2008) 0.84

Non-smoking worksites in the residential construction sector: using an online forum to study perspectives and practices. Tob Control (2010) 0.84

Lessons learned from recruiting socioeconomically disadvantaged smokers into a pilot randomized controlled trial to explore the role of Exercise Assisted Reduction then Stop (EARS) smoking. Trials (2015) 0.84

Widespread inequalities in smoking & smokeless tobacco consumption across wealth quintiles in States of India: Need for targeted interventions. Indian J Med Res (2015) 0.84

Behavioral research in cancer prevention and control: a look to the future. Am J Prev Med (2014) 0.83

Smoking and inequalities. Lancet (2006) 0.83

Educational differences in smoking among adolescents in Germany: what is the role of parental and adolescent education levels and intergenerational educational mobility? Int J Environ Res Public Health (2013) 0.82

How 'male health' fits into the field of urology. Nat Rev Urol (2013) 0.82

Exploring primary care providers' interest in using patient navigators to assist in the delivery of tobacco cessation treatment to low income, ethnic/racial minority patients. J Community Health (2010) 0.82

Dynamics of health behaviours and socioeconomic differences in mortality in the USA. J Epidemiol Community Health (2015) 0.82

The Contribution of Smoking to Educational Gradients in U.S. Life Expectancy. J Health Soc Behav (2015) 0.81

Socioeconomic disparities in telephone-based treatment of tobacco dependence. Am J Public Health (2014) 0.81

The pervasiveness of the socioeconomic gradient of health. Eur J Epidemiol (2007) 0.81

Influence of family and friend smoking on intentions to smoke and smoking-related attitudes and refusal self-efficacy among 9-10 year old children from deprived neighbourhoods: a cross-sectional study. BMC Public Health (2015) 0.81

Smoking and ischemic heart disease disparities between studies, genders, times, and socioeconomic strata. J Cardiovasc Transl Res (2009) 0.81

The effect of tobacco control policy on smoking cessation in relation to gender, age and education in Lithuania, 1994-2010. BMC Public Health (2015) 0.81

Increased risk of oesophageal adenocarcinoma among upstream petroleum workers. Occup Environ Med (2009) 0.81

Smoking in school-aged adolescents: design of a social network survey in six European countries. BMC Res Notes (2015) 0.81

Smoking Cessation and Socioeconomic Status: An Update of Existing Evidence from a National Evaluation of English Stop Smoking Services. Biomed Res Int (2015) 0.80

Intention to quit smoking and concerns about household environmental risks: findings from the Health in Common Study in low-income housing. Cancer Causes Control (2013) 0.80

The impact of life tables adjusted for smoking on the socio-economic difference in net survival for laryngeal and lung cancer. Br J Cancer (2014) 0.80

Update in lung cancer 2006. Am J Respir Crit Care Med (2007) 0.79

Increasing the age for the legal purchase of tobacco in England: impacts on socio-economic disparities in youth smoking. Thorax (2011) 0.79

A pre-post pilot study of a brief, web-based intervention to engage disadvantaged smokers into cessation treatment. Addict Sci Clin Pract (2015) 0.79

Tobacco and the escalating global cancer burden. J Oncol (2011) 0.79

In-person and telephone treatment of tobacco dependence: a comparison of treatment outcomes and participant characteristics. Am J Public Health (2013) 0.79

When Free Is Not for Me: Confronting the Barriers to Use of Free Quitline Telephone Counseling for Tobacco Dependence. Int J Environ Res Public Health (2015) 0.79

The association between parent's health and the educational attainment of their children. Soc Sci Med (2012) 0.78

Retail tobacco exposure: using geographic analysis to identify areas with excessively high retail density. Nicotine Tob Res (2013) 0.78

Interpersonal Communication and Smoking Cessation in the Context of an Incentive-Based Program: Survey Evidence From a Telehealth Intervention in a Low-Income Population. J Health Commun (2015) 0.78

Have Socioeconomic Inequalities in Tobacco Use in India Increased Over Time? Trends From the National Sample Surveys (2000-2012). Nicotine Tob Res (2016) 0.77

The Process of Adapting the Evidence-Based Treatment for Tobacco Dependence for Smokers of Lower Socioeconomic Status. J Addict Res Ther (2015) 0.76

Smoking Patterns and Smoking Cessation Willingness-A Study among Beneficiaries of Government Welfare Assistance in Poland. Int J Environ Res Public Health (2017) 0.76

English Stop-Smoking Services: One-Year Outcomes. Int J Environ Res Public Health (2016) 0.75

Social network and inequalities in smoking amongst school-aged adolescents in six European countries. Int J Public Health (2016) 0.75

Research funding for addressing tobacco-related disease: an analysis of UK investment between 2008 and 2012. BMJ Open (2016) 0.75

Sick Populations and Sick Subpopulations: Reducing Disparities in Cardiovascular Disease Between Blacks and Whites in the United States. Circulation (2016) 0.75

Socioeconomic Inequalities in Smoking and Smoking Cessation Due to a Smoking Ban: General Population-Based Cross-Sectional Study in Luxembourg. PLoS One (2016) 0.75

The associations of personality traits and parental education with smoking behaviour among adolescents. PLoS One (2017) 0.75

Smoking Cessation Carries a Short-Term Rising Risk for Newly Diagnosed Diabetes Mellitus Independently of Weight Gain: A 6-Year Retrospective Cohort Study. J Diabetes Res (2016) 0.75

“Hike up yer skirt, and quit.” what motivates and supports smoking cessation in builders and renovators. Int J Environ Res Public Health (2013) 0.75

Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart (2016) 0.75

Tobacco and Health Disparities. Biomed Res Int (2015) 0.75

An observational study to assess changes in social inequality in smoking-attributable upper aero digestive tract cancer mortality among Canadian males between 1986 and 2001. BMC Public Health (2013) 0.75

Smoking Cessation among Low-Socioeconomic Status and Disadvantaged Population Groups: A Systematic Review of Research Output. Int J Environ Res Public Health (2015) 0.75

Socioeconomic differences in adolescents' smoking: a comparison between Finland and Beijing, China. BMC Public Health (2016) 0.75

Educational disparities in the intention to quit smoking among male smokers in China: a cross-sectional survey on the explanations provided by the theory of planned behaviour. BMJ Open (2016) 0.75

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet (2010) 33.69

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09

Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ (2004) 24.88

Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47

Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62

Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ (2005) 15.50

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27

Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet (2011) 14.16

Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med (2013) 13.92

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64

Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet (2010) 12.28

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

Estimates of global mortality attributable to smoking in 2000. Lancet (2003) 10.52

A nationally representative case-control study of smoking and death in India. N Engl J Med (2008) 10.21

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet (2010) 10.21

Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet (2006) 9.85

GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64

Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Adult and child malaria mortality in India: a nationally representative mortality survey. Lancet (2010) 7.89

50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80

21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med (2013) 7.77

Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71

Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70

Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62

The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet (2012) 7.28

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet (2013) 7.25

Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial. Lancet (2013) 7.04

Can we achieve Millennium Development Goal 4? New analysis of country trends and forecasts of under-5 mortality to 2015. Lancet (2007) 6.72

Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet (2005) 6.63

Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet (2003) 6.58

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol (2009) 6.51

Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet (2012) 6.49

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet (2011) 5.95

Measuring the global burden of disease. N Engl J Med (2013) 5.84

Civil registration systems and vital statistics: successes and missed opportunities. Lancet (2007) 5.67

Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet (2004) 5.19

Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med (2005) 5.05

Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis (2007) 4.87

10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet (2010) 4.73

Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med (2005) 4.64

Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49

Monitoring global health: time for new solutions. BMJ (2004) 4.39

Validation of the symptom pattern method for analyzing verbal autopsy data. PLoS Med (2007) 4.35

Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev (2007) 4.23

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. Lancet (2010) 4.23

Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol (2005) 4.21

Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol (2005) 4.20

Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet (2009) 4.01

Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90

Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet (2010) 3.89

Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ (2004) 3.66

Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med (2014) 3.64

Validity of verbal autopsy procedures for determining cause of death in Tanzania. Trop Med Int Health (2006) 3.62

Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int J Epidemiol (2008) 3.61

Setting international standards for verbal autopsy. Bull World Health Organ (2007) 3.59

The place for harm reduction and product regulation in UK tobacco control policy. J Public Health (Oxf) (2008) 3.58

Role of smoking in global and regional cardiovascular mortality. Circulation (2005) 3.57

Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies. Int J Epidemiol (2008) 3.56

Statistical modeling and projections of lung cancer mortality in 4 industrialized countries. Int J Cancer (2005) 3.53

UK cancer survival statistics. BMJ (2010) 3.44

Adult mortality: time for a reappraisal. Int J Epidemiol (2004) 3.41

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA (2010) 3.34

Mortality registration and surveillance in China: History, current situation and challenges. Popul Health Metr (2005) 3.31

Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics. Bull World Health Organ (2005) 3.30

The way forward. Lancet (2007) 3.28

Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer (2002) 3.26

Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr (2011) 3.21

Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12

Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies. Popul Health Metr (2011) 3.10

Stages of the cigarette epidemic on entering its second century. Tob Control (2012) 2.98

Population deworming every 6 months with albendazole in 1 million pre-school children in North India: DEVTA, a cluster-randomised trial. Lancet (2013) 2.95

Mortality in the Islamic Republic of Iran, 1964-2004. Bull World Health Organ (2007) 2.93

Validation of cause-of-death statistics in urban China. Int J Epidemiol (2007) 2.89

Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med (2004) 2.84

China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol (2011) 2.82

Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr (2003) 2.80

Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries. Lancet (2004) 2.80

Interim measures for meeting needs for health sector data: births, deaths, and causes of death. Lancet (2007) 2.71

Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC). Int J Epidemiol (2005) 2.70

Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. Int J Epidemiol (2006) 2.68